Tradewinds Capital Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History
Bought
Maintained
Sold
Other funds holding TEVA
HIIFS
PF
CI
MMH
MIFH
LIM
Tradewinds Capital Management's TEVA Position: Q2 2026 in Review
Tradewinds Capital Management held its Teva Pharmaceutical Industries Limited (TEVA) position steady in Q2 2026 at 15 shares worth $509. The position accounts for ﹤0.01% of the portfolio, ranked #647.
Tradewinds Capital Management first reported a position in TEVA in Q4 2013 and has held it in 28 quarters since. The position peaked at $11K in Q2 2018. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.
- Tradewinds Capital Management held 15 shares of Teva Pharmaceutical Industries Limited worth $509 as of Q2 2026.
- Tradewinds Capital Management left its Teva Pharmaceutical Industries Limited share count unchanged in Q2 2026.
- Teva Pharmaceutical Industries Limited made up ﹤0.01% of Tradewinds Capital Management's portfolio in Q2 2026, its #647 holding.
- Tradewinds Capital Management first reported a position in Teva Pharmaceutical Industries Limited in Q4 2013 and has held it in 28 quarters since.
- Tradewinds Capital Management's Teva Pharmaceutical Industries Limited position peaked at $11K in Q2 2018.
- 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.
Based on Tradewinds Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.